These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38205878)

  • 1. Linc-ROR inhibits NK cell-killing activity by promoting RXRA ubiquitination and reducing MICB expression in gastric cancer patients.
    Niu Q; Li Z; Jiang H; Hu B
    J Cell Biochem; 2024 Feb; 125(2):e30516. PubMed ID: 38205878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
    Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
    Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Long Noncoding RNA Regulator of Reprogramming in Colon Cancer Progression via Epidermal Growth Factor Receptor Signaling.
    Chen Y; Yang L; Yin D; Feng X; Jie J; Yao D; Chen J
    Technol Cancer Res Treat; 2022; 21():15330338221114707. PubMed ID: 35946134
    [No Abstract]   [Full Text] [Related]  

  • 4. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
    Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
    Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway.
    Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F
    Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
    Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
    Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc-ROR promotes invasion and metastasis of gastric cancer by activating epithelial-mesenchymal transition.
    Liu M; Zhang M; Yin H
    Indian J Pathol Microbiol; 2022; 65(3):545-550. PubMed ID: 35900480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Linc-ROR Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells Through miR-212-3p/FGF7 Axis.
    Mi Y; Li Y; He Z; Chen D; Hong Q; You J
    Cancer Manag Res; 2021; 13():899-912. PubMed ID: 33564265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC_00355 promotes gastric cancer progression by upregulating PHF19 expression through sponging miR-15a-5p.
    Zhang J; Lv W; Liu Y; Fu W; Chen B; Ma Q; Gao X
    BMC Cancer; 2021 Jun; 21(1):657. PubMed ID: 34078310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
    Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
    [No Abstract]   [Full Text] [Related]  

  • 12. Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9.
    Wang L; Yu X; Zhang Z; Pang L; Xu J; Jiang J; Liang W; Chai Y; Hou J; Li F
    J Exp Clin Cancer Res; 2017 Dec; 36(1):182. PubMed ID: 29237490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc-ROR promotes mesenchymal stem cells chondrogenesis and cartilage formation via regulating SOX9 expression.
    Feng L; Yang ZM; Li YC; Wang HX; Lo JHT; Zhang XT; Li G
    Osteoarthritis Cartilage; 2021 Apr; 29(4):568-578. PubMed ID: 33485931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.
    Chen Y; Shen Z; Zhi Y; Zhou H; Zhang K; Wang T; Feng B; Chen Y; Song H; Wang R; Chu X
    Arch Biochem Biophys; 2018 May; 645():117-125. PubMed ID: 29559320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.
    Hou P; Zhao Y; Li Z; Yao R; Ma M; Gao Y; Zhao L; Zhang Y; Huang B; Lu J
    Cell Death Dis; 2014 Jun; 5(6):e1287. PubMed ID: 24922071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
    Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
    J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of hypoxia-signaling pathways by extracellular linc-RoR.
    Takahashi K; Yan IK; Haga H; Patel T
    J Cell Sci; 2014 Apr; 127(Pt 7):1585-94. PubMed ID: 24463816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
    Peng WX; Huang JG; Yang L; Gong AH; Mo YY
    Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc-ROR Regulates
    Yu X; Ma X; Jia Y; Wu X; Yan Z
    Cell Transplant; 2023; 32():9636897231178902. PubMed ID: 37306240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc-ROR has a Potential ceRNA Activity for OCT4A by Sequestering miR-335-5p in the HEK293T Cell Line.
    Taheri Bajgan E; Gholipour A; Faghihi M; Mowla SJ; Malakootian M
    Biochem Genet; 2022 Jun; 60(3):1007-1024. PubMed ID: 34669056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.